articleTop 1% cited

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

Vaccine · 2007 · Vol. 25(26) · pp. 4931–4939

Sven‐Eric Olsson✉(Danderyds sjukhus)Luisa L. Villa(Ludwig Cancer Research)Ronaldo Lúcio Rangel Costa(Instituto Brasileiro de Controle do Câncer)Carlos Alberto Petta(Universidade Estadual de Campinas (UNICAMP))Rosíres Pereira de AndradeChristian Malm(University of Helsinki)Ole‐Erik Iversen(University of Bergen)John Høye(Drammen Hospital)Margareta Steinwall(Malmö University)Grete Riis-JohannessenAgneta Andersson‐Ellström(University of Gothenburg)Kristina Elfgren(Integrated Cardio Metabolic Centre)Geo von Krogh(Karolinska University Hospital)Matti LehtinenJorma Paavonen(University of Helsinki)Gretchen Tamms(United States Military Academy)Katherine Giacoletti(United States Military Academy)Lisa Lupinacci(United States Military Academy)Mark T. Esser(United States Military Academy)Scott Vuocolo(United States Military Academy)Alfred J. Saah(United States Military Academy)Eliav Barr(United States Military Academy)

View via DOI Publisher page

Cervical Cancer and HPV Research Hepatitis B Virus Studies Immunotherapy and Immune ResponsesMedicineVaccinationPlaceboRegimenImmune systemImmunologyImmunityVaccine efficacyAdverse effectInternal medicine

MeSH terms

AdolescentAdultAntibodies, ViralDose-Response Relationship, DrugDouble-Blind MethodFollow-Up StudiesHumansImmunization ScheduleImmunologic MemoryPapillomavirus InfectionsHuman papillomavirus 11Human papillomavirus 18Human papillomavirus 16Papillomavirus Vaccines

Citations

455

FWCI

35.47

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years